forecast

CAR T-Cell Therapy Could Extend Beyond Blood Cancers

CAR T-cell therapy has been very successful against leukemias, lymphomas, and myelomas, and Marrazzo expects it to be applied in the next 5 to 10 years to solid tumors that make up the other 93 percent of cancer, including lung, breast, and colon cancer.

forecastpending

Speaker

Jeff

Evidence Quote

“I think over the course of the next 5 to 10 years or even sooner, we're going to see the first progress in applying this T-cell engineering approach”

Source

Compounding For A Cure— Joys of Compounding
Created: 11/11/2026, 6:53:25 PM

Your notes

Loading notes...